Reply to Francesco Montorsi, Simone Scuderi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Melline G.M. Schilham, Mark Rijpkema, Tom Scheenen, et al. How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come. Eur Urol 2022;82:578-80

Autor: Melline G.M. Schilham, Mark Rijpkema, Tom Scheenen, Rick Hermsen, Jelle O. Barentsz, J.P.Michiel Sedelaar, Heidi Kusters-Vandevelde, Linda G.W. Kerkmeijer, Diederik M. Somford, Martin Gotthardt

Publikováno v: European Urology, 83, 5, pp. e133-e134

Item does not contain fulltext

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d303e94c30524cc1c670b4fb4b47acf
https://doi.org/10.1016/j.eururo.2023.01.023

Reply to Francesco Montorsi, Simone Scuderi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Melline G.M. Schilham, Mark Rijpkema, Tom Scheenen, et al. How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come. Eur Urol 2022;82:578-80.

Autor: Schilham MGM; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands; Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands. Electronic address: melline.schilham@radboudumc.nl., Rijpkema M; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands., Scheenen T; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands., Hermsen R; Department of Nuclear Medicine, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Barentsz JO; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands., Sedelaar JPM; Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands., Kusters-Vandevelde H; Department of Pathology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Kerkmeijer LGW; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Somford DM; Prosper Prostate Cancer Clinics, Nijmegen/Eindhoven, The Netherlands; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Gotthardt M; Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.

Publikováno v: European urology [Eur Urol] 2023 May; Vol. 83 (5), pp. e133-e134. Date of Electronic Publication: 2023 Feb 11.

Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer

Autor: Morteza Esmaeili, Nassim Tayari, Tom Scheenen, Mattijs Elschot, Elise Sandsmark, Helena Bertilsson, Arend Heerschap, Kirsten M. Selnæs, Tone F. Bathen

Publikováno v: Frontiers in Oncology, Vol 8 (2018)

Purpose: To investigate the associations of metabolite levels derived from magnetic resonance spectroscopic imaging (MRSI) and 18F-fluciclovine positron emission tomography (PET) with prostate tissue characteristics.Methods: In a cohort of 19 high-ri

Externí odkaz: https://doaj.org/article/25a99718ff574419a4d04c990e19bcac

In vivo clearance of

Autor: Alexander H J, Staal, Katrin, Becker, Oya, Tagit, N, Koen van Riessen, Olga, Koshkina, Andor, Veltien, Pascal, Bouvain, Kimberley R G, Cortenbach, Tom, Scheenen, Ulrich, Flögel, Sebastian, Temme, Mangala, Srinivas

Publikováno v: Biomaterials. 261

Perfluorocarbons hold great promise both as imaging agents, particularly for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b60417de38ff2107008d61ca917351c1
https://pubmed.ncbi.nlm.nih.gov/32927288

Advancing MRI with magnetic nanoparticles: a comprehensive review of translational research and clinical trials.

Autor: Lapusan, Radu, Borlan, Raluca, Focsan, Monica

Publikováno v: Nanoscale Advances; 5/7/2024, Vol. 6 Issue 9, p2234-2259, 26p